Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. N-(3-(4-(4-cyclohexylmethanesulfonylaminobutyl)piperazin-1-yl)phenyl)acetamide
2. Prx 00023
3. Prx-00023
4. Prx00023
1. 740873-06-7
2. Prx-00023
3. Naluzotan (free Base)
4. Lq54e5b4ew
5. Chembl209821
6. Unii-lq54e5b4ew
7. Acetamide, N-(3-(4-(4-(((cyclohexylmethyl)sulfonyl)amino)butyl)-1-piperazinyl)phenyl)-
8. N-(3-(4-(4-(((cyclohexylmethyl)sulfonyl)amino)butyl)piperazin-1-yl)phenyl)acetamide
9. N-(3-(4-(4-((cyclohexylmethyl)sulfonamido)butyl)piperazin-1-yl)phenyl)acetamide
10. Naluzotan [usan]
11. Naluzotan [usan:inn]
12. N-(3-(4-(4-cyclohexylmethanesulfonylaminobutyl)piperazin-1-yl)phenyl)acetamide
13. N-(3-[4-(4-cyclohexylmethanesulfonylaminobutyl)piperazin-1-yl]phenyl)acetamide
14. N-[3-[4-[4-(cyclohexylmethylsulfonylamino)butyl]piperazin-1-yl]phenyl]acetamide
15. Prx 00023
16. Naluzotan [inn]
17. Naluzotan (usan/inn)
18. Schembl678016
19. Dtxsid40995527
20. Bcp20177
21. Prx00023
22. Zinc3963096
23. Bdbm50187377
24. Cs-6740
25. Db05562
26. Sb16847
27. Hy-14848
28. Db-115004
29. D09358
30. 833c676
31. L001689
32. Q6961039
33. N-(3-(4-(4-(cyclohexylmethylsulfonamido)butyl)piperazin-1-yl)phenyl)acetamide
34. N-[3-[4-[4-[(cyclohexylmethylsulfonyl)amino]butyl]piperazin-1-yl]phenyl]acetamide
35. N-{3-[4-(4-cyclohexylmethanesulfonylamino-butyl)-piperazin-1-yl]-phenyl}-acetamide
Molecular Weight | 450.6 g/mol |
---|---|
Molecular Formula | C23H38N4O3S |
XLogP3 | 3.2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 10 |
Exact Mass | 450.26646226 g/mol |
Monoisotopic Mass | 450.26646226 g/mol |
Topological Polar Surface Area | 90.1 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 638 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in anxiety disorders and depression.
Serotonin 5-HT1 Receptor Agonists
Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. (See all compounds classified as Serotonin 5-HT1 Receptor Agonists.)
ABOUT THIS PAGE
A Naluzotan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Naluzotan, including repackagers and relabelers. The FDA regulates Naluzotan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Naluzotan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Naluzotan supplier is an individual or a company that provides Naluzotan active pharmaceutical ingredient (API) or Naluzotan finished formulations upon request. The Naluzotan suppliers may include Naluzotan API manufacturers, exporters, distributors and traders.
Naluzotan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Naluzotan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Naluzotan GMP manufacturer or Naluzotan GMP API supplier for your needs.
A Naluzotan CoA (Certificate of Analysis) is a formal document that attests to Naluzotan's compliance with Naluzotan specifications and serves as a tool for batch-level quality control.
Naluzotan CoA mostly includes findings from lab analyses of a specific batch. For each Naluzotan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Naluzotan may be tested according to a variety of international standards, such as European Pharmacopoeia (Naluzotan EP), Naluzotan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Naluzotan USP).
LOOKING FOR A SUPPLIER?